Updated:
Bio Essence Corp
Bio Essence Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001723059, and its reported industry is...
Overview
Bio Essence Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001723059, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-03-27, it reported annual revenue of USD 1,897,566; net income of USD 896,197; total assets of USD 422,474 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Bio Essence Corp
- Classification
- Public company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Irvine, CA, United States
- Incorporated in
- CA
- Fiscal year end
- December 31
- Ticker
- OTC: BIOE
- SEC CIK
- 0001723059
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2025USD | $1.9M | $896,197 | $422,474 | — | $1.6M | |
| FY2024USD | $323,940 | -$1.3M | $281,024 | $1,371 | $623,865 | |
| FY2023USD | $551,506 | -$971,879 | $2.7M | $114 | -$1.0M | |
| FY2022USD | $985,757 | -$809,679 | $1.5M | $6,262 | -$706,824 |
FY2023. Total assets, Operating cash flow: shown as originally filed; later filings report different values for the same periods.
FY2022. Revenue, Operating cash flow: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-Q | QUARTERLY REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| 8-K | CURRENT REPORT | ||
| 10-K | ANNUAL REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| 10-K | ANNUAL REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| 8-K | FORM 8-K | ||
| 10-Q | QUARTERLY REPORT | ||
| 8-K | CURRENT REPORT |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Bio Essence Corp in Altss
Track this company’s investors, transactions and relationships in Altss.